“’Gravely disabled’ patient left to fend for himself,” that is the charge filed in a civil enforcement action against Scripps Health in San Diego. The patient was diagnosed with schizophrenia and suffered from hallucinations, making it impossible for him to care for himself. He was hospitalized, delusional, refusing to attend to his basic needs, agitated, frequently cursing, etc. and the …
On June 1, 2021, Aklermes announced FDA approval of LYBALVI™ for the treatment of schizophrenia and Bipolar I disorder. The following was published as part of their press release announcement: “Schizophrenia and bipolar I disorder are complex, chronic diseases and there remains a persistent need for new medications with proven efficacy and safety. Olanzapine, a highly-efficacious atypical antipsychotic, is associated …
